DaVita Inc.
Approved Evidence
DaVita paid $34.5 million to resolve additional kickback allegations
DaVita agreed to pay $34.49 million in 2024 to resolve allegations that it paid kickbacks to induce referrals to its former DaVita Rx pharmacy subsidiary and to dialysis centers. Source: https://www.justice.gov/archives/opa/pr/davita-pay-over-34m-resolve-allegations-illegal-kickbacks
DaVita paid $450 million over unnecessary dialysis drug waste billed to government programs
DaVita paid $450 million to resolve allegations that it knowingly created unnecessary waste when administering dialysis drugs Zemplar and Venofer and then billed federal healthcare programs for the avoidable waste. Source: https://www.justice.gov/archives/opa/pr/justice-department-recovers-over-35-billion-false-claims-act-cases-fiscal-year-2015
DaVita paid $350 million to resolve illegal patient-referral kickback allegations
DaVita agreed to pay $350 million to resolve allegations that it offered physicians lucrative dialysis-clinic investment transactions and related agreements to induce patient referrals. A further $39 million civil forfeiture was tied to two joint-venture transactions. Source: https://www.justice.gov/archives/opa/pr/davita-pay-350-million-resolve-allegations-illegal-kickbacks